NEW HAVEN, Conn.--(BUSINESS WIRE)--Rib-X Pharmaceuticals, Inc., a development-stage antibiotics company with a broad product pipeline based on its innovative discovery platform, today announced that it will be participating in a panel session on drug discovery and development of novel treatments for drug-resistant infections, taking place on May 5 at the 2010 BIO International Convention in Chicago.
